Exaggerated QT prolongation after cardioversion of atrial fibrillation (Q78106174)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440151 AND SRC:MED&resulttype=core&format=json

11 December 2019

title

Exaggerated QT prolongation after cardioversion of atrial fibrillation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440151 AND SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440151 AND SRC:MED&resulttype=core&format=json

11 December 2019

author name string

A M Choy

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440151 AND SRC:MED&resulttype=core&format=json

11 December 2019

S Dell'Orto

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440151 AND SRC:MED&resulttype=core&format=json

11 December 2019

D M Roden

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440151 AND SRC:MED&resulttype=core&format=json

11 December 2019

language of work or name

English

0 references

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440151 AND SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

11 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440151 AND SRC:MED&resulttype=core&format=json

11 December 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440151 AND SRC:MED&resulttype=core&format=json

11 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440151 AND SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

396-401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440151 AND SRC:MED&resulttype=core&format=json

Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Sotalol-induced torsade de pointes: management with magnesium infusion

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

A randomized, double-blind, placebo-controlled, dose-ranging study of dofetilide in patients with inducible sustained ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Plasma atrial natriuretic peptide, aldosterone, and plasma renin activity responses to gradual changes in dietary sodium intake

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

A new method for constant plasma drug concentrations: application to lidocaine

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Electrophysiological Effects of atrial Natriuretic Peptide on the Cardiac Conduction System in Man

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Normalization of acquired QT prolongation in humans by intravenous potassium.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Chemical cardioversion of atrial fibrillation with intravenous dofetilide

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

The QT interval in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

The QT interval during reflex cardiovascular adaptation

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: no evidence for "reverse use dependent" block

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Human muscle nerve sympathetic activity in cardiac arrhythmias.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Serum Electrolytes and Catecholamines After Cardioversion From Ventricular Tachycardia and Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Changes in plasma concentrations of atrial natriuretic peptides after cardioversion of chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Atrionatriuretic peptide transforms cardiac sodium channels into calcium-conducting channels

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Effects of atrionatriuretic factor on Ca2 current and Cai-independent transient outward K current in human atrial cells

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

KVLQT1 C-Terminal Missense Mutation Causes a Forme Fruste Long-QT Syndrome

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Taking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Holter recordings

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Two components of cardiac delayed rectifier K current. Differential sensitivity to block by class III antiarrhythmic agents

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Prediction of sotalol-induced maximum steady-state QTc prolongation from single-dose administration in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

Early after-depolarizations and torsade de pointes: implications for the control of cardiac arrhythmias by prolonging repolarization

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(99)00226-0

7 January 2021

10.1016/S0735-1097(99)00226-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440151 AND SRC:MED&resulttype=core&format=json

11 December 2019

1 reference